module 8 antiarrhythmics class 1 Flashcards
cardiac action potential has 5 phases
0: depolarization (Na influx)
1: Na channels close, fast K efflux
2: plateau: Ca influx
3: Ca channels close, K efflux
4: repolarization
Class 1a MOA
inhibit Na fast channels -> slowing of phase 0 depolarization and prolonging repolarization.
Class 1a indications
ventricular ectopy
conversion of a-fib and flutter
wolfe parkinson white
Class 1a drugs
procainamide
quinidine
disopyramide
Procainamide AE
QT prolongation
lupus-like syndrome
rash
agranulocytosis
quinidine AE
QT prolongation hepatitis hemolysis thrombocytopenia N/V/D inc. digoxin levels
disopyramide AE
QT prolongation anticholingeric effects negative inotrope (do not use with HF)
class 1b MOA
shorten phase 3 repolarization and dec. the duration of the AP
class 1b drugs
lidocaine
mexiletine
lidocaine
inpatient use, admin IV AE: - seizures - delirium - paresthesis
Class 1b uses
ventricular arrhythmias
mexiletine
oral analogue of lidocaine
used for long-term tx
class 1c MOA
slow phase 0 depolarization
inhibit fast Na channel, slow AV conduction
Class 1c drugs
flecainide
propafenone
Class 1c contraindication
structural heart disease
- valve disease
- HF
inc. mortality
flecanide MOA
inhibits fast Na channels -> slow conduction
blocks K channels -> longer AP
flecanide uses
maintain SR in a-fib or flutter
treat refractory ventricular arrhythmia
flecanide AE
blurred vision
dizzy
nausea
propafanone MOA
slows conduction in all cardiac tissue
propafanone AE
proarrhythmic effects moderate negative inotrope dizzy conduction abnormalities - can worsen HF - can cause bronchospasm